Cowen and Company’s Alder Biopharmaceuticals ALDR Stock Holding History

Cowen and Company’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-124,300	Closed	-$19K	–	704
2019 Q3	$19K	Buy	+124,300	New	+$1.42M	﹤0.01%	380

Cowen and Company's ALDR Position: Q4 2019 in Review

Cowen and Company sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 23,937 shares — an estimated $451K sold.

Cowen and Company first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $451K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Cowen and Company reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Cowen and Company sold 23,937 Alder Biopharmaceuticals shares in Q4 2019, an estimated $451K.
Cowen and Company first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
Cowen and Company's Alder Biopharmaceuticals position peaked at $451K in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Cowen and Company's 13F filing for Q4 2019, filed 11 Feb 2020.